Keshu Hu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Cancer Stem Cells

Top Venues

Cell death & disease

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Jiayu Zhang, Yu Dong, Shan Yu, Keshu Hu, Lingyun Zhang, Min Xiong, Mengling Liu, Xun Sun, Suyao Li, Yitao Yuan, Chi Zhang, Mengxuan Zhu, Yichou Wei, Yanjing Zhu, Yiyi Yu, Pengfei Zhang, Tianshu Liu
IL-4/IL-4R axis signaling drives resistance to immunotherapy by inducing the upregulation of Fcγ receptor IIB in M2 macrophages. Cell death & disease 15 (7) (2024)
Jiayu Zhang, Yu Dong, Shan Yu, Keshu Hu, Lingyun Zhang, Min Xiong, Mengling Liu, Xun Sun, Suyao Li, Yitao Yuan, Chi Zhang, Mengxuan Zhu, Yichou Wei, Yanjing Zhu, Yiyi Yu, Pengfei Zhang, Tianshu Liu
IL-4/IL-4R axis signaling drives resistance to immunotherapy by inducing the upregulation of Fcγ receptor IIB in M2 macrophages. Cell death & disease 15 (7) (2024)
Keshu Hu, Yu Dong, Jiayu Zhang, Mengling Liu, Xun Sun, Xin Cao, Pengfei Zhang, Tianshu Liu
Sulfarotene Inhibits Colorectal Cancer via Mitigating Natural-Killer-Cell-Induced Stemness. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Keshu Hu, Yu Dong, Jiayu Zhang, Mengling Liu, Xun Sun, Xin Cao, Pengfei Zhang, Tianshu Liu
Sulfarotene Inhibits Colorectal Cancer via Mitigating Natural-Killer-Cell-Induced Stemness. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Keshu Hu, Yu Dong, Jiayu Zhang, Mengling Liu, Xun Sun, Xin Cao, Pengfei Zhang, Tianshu Liu
Sulfarotene Inhibits Colorectal Cancer via Mitigating Natural-Killer-Cell-Induced Stemness. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Jiayu Zhang, Yu Dong, Shan Yu, Keshu Hu, Lingyun Zhang, Min Xiong, Mengling Liu, Xun Sun, Suyao Li, Yitao Yuan, Chi Zhang, Mengxuan Zhu, Yichou Wei, Yanjing Zhu, Yiyi Yu, Pengfei Zhang, Tianshu Liu
IL-4/IL-4R axis signaling drives resistance to immunotherapy by inducing the upregulation of Fcγ receptor IIB in M2 macrophages. Cell death & disease 15 (7) (2024)
Jiayu Zhang, Yu Dong, Shan Yu, Keshu Hu, Lingyun Zhang, Min Xiong, Mengling Liu, Xun Sun, Suyao Li, Yitao Yuan, Chi Zhang, Mengxuan Zhu, Yichou Wei, Yanjing Zhu, Yiyi Yu, Pengfei Zhang, Tianshu Liu
IL-4/IL-4R axis signaling drives resistance to immunotherapy by inducing the upregulation of Fcγ receptor IIB in M2 macrophages. Cell death & disease 15 (7) (2024)